PT1210943E - Nova utilizacao para budesonida e formoterol - Google Patents

Nova utilizacao para budesonida e formoterol

Info

Publication number
PT1210943E
PT1210943E PT02001670T PT02001670T PT1210943E PT 1210943 E PT1210943 E PT 1210943E PT 02001670 T PT02001670 T PT 02001670T PT 02001670 T PT02001670 T PT 02001670T PT 1210943 E PT1210943 E PT 1210943E
Authority
PT
Portugal
Prior art keywords
formoterol
budesonide
new used
new
relates
Prior art date
Application number
PT02001670T
Other languages
English (en)
Portuguese (pt)
Inventor
Carl-Axel Bauer
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20408325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1210943(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT1210943E publication Critical patent/PT1210943E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT02001670T 1997-09-19 1998-09-09 Nova utilizacao para budesonida e formoterol PT1210943E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703407A SE9703407D0 (sv) 1997-09-19 1997-09-19 New use

Publications (1)

Publication Number Publication Date
PT1210943E true PT1210943E (pt) 2006-09-29

Family

ID=20408325

Family Applications (2)

Application Number Title Priority Date Filing Date
PT02001670T PT1210943E (pt) 1997-09-19 1998-09-09 Nova utilizacao para budesonida e formoterol
PT98944373T PT1014993E (pt) 1997-09-19 1998-09-09 Nova utilizacao de budenosido e formoterol

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT98944373T PT1014993E (pt) 1997-09-19 1998-09-09 Nova utilizacao de budenosido e formoterol

Country Status (38)

Country Link
US (2) US7897646B2 (forum.php)
EP (2) EP1014993B1 (forum.php)
JP (1) JP2001517630A (forum.php)
KR (1) KR20010024140A (forum.php)
CN (1) CN1149998C (forum.php)
AR (1) AR013506A1 (forum.php)
AT (2) ATE329599T1 (forum.php)
AU (1) AU757235B2 (forum.php)
BR (1) BR9812325A (forum.php)
CA (1) CA2302700C (forum.php)
CY (1) CY1106156T1 (forum.php)
CZ (1) CZ295250B6 (forum.php)
DE (2) DE69807239T2 (forum.php)
DK (2) DK1210943T3 (forum.php)
EE (1) EE04297B1 (forum.php)
ES (2) ES2266322T3 (forum.php)
HK (1) HK1045812B (forum.php)
HU (1) HUP0003848A2 (forum.php)
ID (1) ID24838A (forum.php)
IL (1) IL134773A (forum.php)
IN (1) IN190791B (forum.php)
IS (1) IS2715B (forum.php)
MX (1) MXPA00002615A (forum.php)
MY (1) MY127812A (forum.php)
NO (1) NO327176B1 (forum.php)
NZ (1) NZ503173A (forum.php)
PL (1) PL190782B1 (forum.php)
PT (2) PT1210943E (forum.php)
RU (1) RU2199322C2 (forum.php)
SA (1) SA98190773B1 (forum.php)
SE (1) SE9703407D0 (forum.php)
SI (2) SI1210943T1 (forum.php)
SK (1) SK285330B6 (forum.php)
TR (1) TR200000726T2 (forum.php)
TW (1) TW546140B (forum.php)
UA (1) UA72446C2 (forum.php)
WO (1) WO1999015182A1 (forum.php)
ZA (1) ZA988516B (forum.php)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
CZ303154B6 (cs) * 1998-11-13 2012-05-09 Jagotec Ag Suchá prášková formulace k inhalaci obsahující stearát horecnatý
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
DE60221640T2 (de) * 2001-02-06 2008-05-21 Innovata Biomed Ltd., St. Albans Bimodale trockenpulverzusammensetzung zur inhalation
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
KR20050056222A (ko) * 2002-09-30 2005-06-14 아쿠스피어 인코포레이티드 흡입용 지속 방출형 다공성 미세입자
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
PL1921919T3 (pl) 2005-07-14 2012-09-28 Lithera Inc Ulepszona lipolityczna formulacja o podtrzymywanym uwalnianiu do traktowania lokalnej tkanki tłuszczowej
CA2631492A1 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ，インク． 甲状腺眼症の治療のための方法、組成物及び製剤
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
PL3111926T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
CA2764867C (en) * 2009-06-09 2016-05-17 Elevation Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
CN102000090A (zh) * 2009-08-31 2011-04-06 北京利乐生制药科技有限公司 一种以布地奈德与阿福特罗为活性成分的复方制剂
MX2012008171A (es) * 2010-01-15 2012-12-17 Lithera Inc Formulaciones aglomeradas liofilizadas.
JP2013543897A (ja) 2010-11-24 2013-12-09 リセラ，インク． 脂肪症及び輪郭の膨れの美容処置のための、選択的な、親油性の、及び長時間作用性のベータアゴニストの単剤療法製剤、及び方法
WO2012129237A2 (en) 2011-03-20 2012-09-27 Trustees Of Boston University Therapeutic agent for emphysema and copd
CN102362860A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
HK1219059A1 (zh) 2013-03-15 2017-03-24 珍珠治疗公司 用於微粒晶體材料的狀態調節的方法和系統
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
EP3383366B2 (en) 2015-12-04 2024-06-05 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
CA3103679A1 (en) 2018-06-14 2019-12-19 Astrazeneca Uk Limited Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
WO2021048171A1 (en) * 2019-09-10 2021-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to improve phagocytosis
US12329759B2 (en) 2019-10-17 2025-06-17 Trustees Of Boston University Methods and compositions relating to lung function

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
DK0416950T3 (da) 1989-09-08 1993-10-11 Glaxo Group Ltd Medikamenter
US5250286A (en) * 1990-05-07 1993-10-05 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl) 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5444521A (en) 1991-07-15 1995-08-22 Canon Kabushiki Kaisha Image fixing device capable of controlling heating overshoot
EP1086697A2 (en) 1991-12-18 2001-03-28 AstraZeneca AB New combination of formoterol and budesonide
SK282826B6 (sk) * 1991-12-18 2002-12-03 Aktiebolaget Astra Farmaceutická kompozícia na podávanie inhaláciou s obsahom formoterolu a budesonidu a jej použitie
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
SE9700134D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
GB9519692D0 (en) 1995-09-27 1995-11-29 Quillin Helen Atomising nozzle
JP2000501104A (ja) * 1995-11-24 2000-02-02 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ キノリン誘導体
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
CA2295076A1 (en) 1997-06-27 1999-01-07 Astra Aktiebolag New combination of antiasthma medicaments
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination

Also Published As

Publication number Publication date
CN1271287A (zh) 2000-10-25
IN190791B (forum.php) 2003-08-23
HK1045812B (en) 2006-12-22
TR200000726T2 (tr) 2000-09-21
AU9192898A (en) 1999-04-12
DE69834955D1 (de) 2006-07-27
DK1210943T3 (da) 2006-09-18
NZ503173A (en) 2001-08-31
UA72446C2 (uk) 2005-03-15
CN1149998C (zh) 2004-05-19
PL190782B1 (pl) 2006-01-31
WO1999015182A1 (en) 1999-04-01
HK1045812A1 (en) 2002-12-13
EP1014993B1 (en) 2002-08-14
DK1014993T3 (da) 2002-11-11
CZ295250B6 (cs) 2005-06-15
US20020042404A1 (en) 2002-04-11
CY1106156T1 (el) 2011-06-08
DE69807239T2 (de) 2003-04-10
SK285330B6 (sk) 2006-11-03
BR9812325A (pt) 2000-09-05
ATE329599T1 (de) 2006-07-15
US20060189587A9 (en) 2006-08-24
SA98190773B1 (ar) 2006-10-02
EE04297B1 (et) 2004-06-15
AR013506A1 (es) 2000-12-27
JP2001517630A (ja) 2001-10-09
PT1014993E (pt) 2002-12-31
US7897646B2 (en) 2011-03-01
KR20010024140A (ko) 2001-03-26
RU2199322C2 (ru) 2003-02-27
NO327176B1 (no) 2009-05-04
NO20001401D0 (no) 2000-03-17
DE69807239D1 (de) 2002-09-19
ES2266322T3 (es) 2007-03-01
IL134773A (en) 2005-03-20
ATE222106T1 (de) 2002-08-15
CZ2000950A3 (cs) 2000-06-14
SI1014993T1 (en) 2003-02-28
SK3892000A3 (en) 2000-12-11
ID24838A (id) 2000-08-24
MY127812A (en) 2006-12-29
CA2302700A1 (en) 1999-04-01
US20110097282A1 (en) 2011-04-28
MXPA00002615A (es) 2002-04-24
SE9703407D0 (sv) 1997-09-19
SI1210943T1 (sl) 2006-10-31
IS5407A (is) 2000-03-15
EP1210943A1 (en) 2002-06-05
IL134773A0 (en) 2001-04-30
IS2715B (is) 2011-02-15
NO20001401L (no) 2000-03-17
US8461211B2 (en) 2013-06-11
TW546140B (en) 2003-08-11
CA2302700C (en) 2010-11-23
EP1014993A1 (en) 2000-07-05
EP1210943B1 (en) 2006-06-14
PL339295A1 (en) 2000-12-04
EE200000145A (et) 2001-02-15
AU757235B2 (en) 2003-02-06
HUP0003848A2 (hu) 2001-08-28
ZA988516B (en) 1999-03-19
DE69834955T2 (de) 2007-01-25
ES2182357T3 (es) 2003-03-01

Similar Documents

Publication Publication Date Title
PT1210943E (pt) Nova utilizacao para budesonida e formoterol
DE60010662D1 (de) Kombinationen von formoterol und fluticasonpropionat für asthma
ATE201138T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
ID27937A (id) Penggunaan komposisi yang mengandung formoterol dan budesonida untuk pencegahan atau pengobatan kondisi asma yang akut
FI971412A7 (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasie n estäjinä
BR9711530A (pt) Combina-Æo de terapia para tratamento de psicoses
FI964314A7 (fi) Substituoidut sulfonamidit selektiivisinä beta3-agonisteina diabeteksen ja liikalihavuuden hoitoon
DE69525107D1 (de) Gasmischeinrichtungen für Wiederbelebungs- und Beatmungsvorrichtungen
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
FI972781L (fi) Menetelmät ja koostumukset allergisen nuhan ja muiden sairauksien hoitamiseksi käyttäen dekarboetokyloratadieeniä
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
FI971151A7 (fi) Kolesterolin absorption inhibiittorin ja kolesterolin synteesin inhibi ittorin yhdistelmä
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
DE69838728D1 (de) Methoden und zusammensetzungen zum wirksameren abfangen von sauerstoff
BR8401148A (pt) Composicao descorante para limpeza do corpo e metodo de limpar e desodorizar simultaneamente o corpo
DE69527749D1 (de) Kugelförmige Aktivkohle zur Behandlung von Bauchentzündungen
FI971750A0 (fi) Koostumuksia multippeliskleroosia varten ja sen hoito
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69519602D1 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
BR9510554A (pt) Uso de moléculas de ligação de mch-ii e/ou moléculas de imitação para a prevenção e/ou tratamento de doenças inflamatórias
FI963264A7 (fi) Tromboksaani A2-välitteisten sairauksien ennaltaestoon ja hoitoon tarkoitettu aine
DE69418931D1 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
IS5534A (is) Ný notkun staðdeyfandi efna gegn æðahöfuðverkjum
PT826814E (pt) Processo e dispositivo para o tratamento de material fibroso